Analyst Ratings February 19, 2026

DA Davidson raises Fluor price target to $60, citing SMR monetization and cleaner guidance

Analyst sees backlog inflection potential across energy, power, mining and pharma as valuation converges with peers

By Derek Hwang FLR
DA Davidson raises Fluor price target to $60, citing SMR monetization and cleaner guidance
FLR

Summary: DA Davidson increased its price objective on Fluor Corp. (FLR) to $60 from $55 while keeping a Buy rating, reflecting the company’s fourth-quarter 2026 guidance and ongoing small modular reactor (SMR) monetization efforts. The new target implies roughly 16% upside from Fluor’s current price of $51.70. The analyst house highlighted opportunities across energy, power, mining and pharmaceutical sectors that could drive an inflection in backlog and valuation alignment with industry peers. InvestingPro data cited in the update shows analysts expect Fluor to return to profitability this year, with an EPS forecast of $2.48 for fiscal 2026.

Key Points

  • DA Davidson raised its Fluor price target to $60 from $55 and kept a Buy rating; the new target implies about 16% upside from the $51.70 share price.
  • The analyst update incorporates fourth-quarter 2026 guidance and Fluor's small modular reactor (SMR) monetization efforts, and highlights opportunities in energy, power, mining and pharmaceuticals that may drive backlog inflection and valuation convergence.
  • Valuation metrics used by DA Davidson are 12 times 2026 EBITDA and 10 times 2027 EBITDA, factoring in a pro forma balance sheet post-SMR monetization; Fluor shows a current ratio of 1.91 and an Altman Z-Score of 3.64.

DA Davidson lifts target, reiterates Buy

DA Davidson has raised its price target on Fluor Corp. (NYSE: FLR) to $60 from $55 and maintained a Buy rating on the stock. The revised target equates to about 16% upside relative to the company’s current share price of $51.70. Fluor shares have recently shown notable momentum, gaining 10.88% over the last week and rising 27.78% year-to-date.

Drivers behind the change

The firm said its updated outlook incorporates Fluor’s guidance for the fourth quarter of fiscal 2026 and the company’s activities around monetizing its small modular reactor (SMR) assets. In DA Davidson’s view, these developments should help clarify Fluor’s strategic direction over time and open room for growth in several end markets, including energy, power, mining and pharmaceuticals.

DA Davidson pointed to analysts’ expectations, as reflected in InvestingPro data, that Fluor will be profitable this year with an EPS forecast of $2.48 for fiscal 2026. The firm argued that opportunities in the cited sectors can spur an inflection in the company’s backlog and help support convergence in valuation toward peers in the industry.

Valuation and balance-sheet context

The $60 price target corresponds to 12 times DA Davidson’s estimate of Fluor’s 2026 EBITDA and 10 times its estimate for 2027 EBITDA. That valuation framework takes into account a pro forma balance sheet position following fourth-quarter SMR monetization and the current value of Fluor’s remaining ownership stake in SMR.

DA Davidson also highlighted Fluor’s liquidity and broader financial stability, citing a current ratio of 1.91 and an Altman Z-Score of 3.64. Those metrics indicate that the company’s liquid assets exceed near-term obligations and that it exhibits a degree of financial resilience.

Known variability and tax considerations

The analyst house acknowledged that valuation remains sensitive to changes in the prevailing equity value of the SMR business. DA Davidson further noted tax consequences associated with Fluor’s monetization of its remaining SMR stake, and it said ongoing results will continue to reflect both operating performance and financial impacts from legacy projects.

Research and wider analyst context

DA Davidson described itself as constructive on Fluor’s medium-term and long-term prospects, a view that aligns with an InvestingPro tip pointing to expected growth in net income this year. The same InvestingPro reference also notes that, despite anticipated profitability, Fluor currently trades above its Fair Value estimate. For investors seeking additional company-level analysis, InvestingPro provides a Pro Research Report covering Fluor and other US-listed names.

Recent quarterly results

Fluor reported fourth-quarter 2025 results that modestly missed analyst expectations. The company posted an EPS of $0.33, trailing the forecast of $0.35, and saw revenue of $4.18 billion versus an expected $4.26 billion. Despite those shortfalls, Fluor communicated optimism about its strategic initiatives and a positive outlook for 2026. The company’s shares have shown resilience in recent trading, though the focus of the analysis remains on underlying financial and strategic developments.


Contextual note

The information above reflects DA Davidson’s updated view and the company-reported results cited. The firm’s outlook and valuation assessment emphasize SMR monetization, sector opportunities and balance-sheet strength as central elements in its thesis for Fluor.

Risks

  • Valuation sensitivity tied to the prevailing equity value of Fluor's SMR holdings could produce variability in the company’s market valuation - this impacts investor sentiment and valuation comparisons within energy and industrial sectors.
  • Tax consequences from monetizing Fluor’s remaining stake in SMR could affect net proceeds and financial statements - relevant to corporate finance and tax planning for the company.
  • Ongoing results will continue to reflect performance and legacy project financial impacts, which may constrain near-term earnings and revenue trends and affect perceptions across construction, engineering and mining markets.

More from Analyst Ratings

DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026 BWS Financial Boosts A10 Networks Price Target Citing AI-Driven Network Traffic Feb 20, 2026